CD47 and cancer: To identify mechanisms exploited by cancer cells against PrCR beyond CD47 upregulation, we first knocked out CD47 expression in SW620, a human colon cancer line, by transducing the cells with TALEN (transcription activator-like effector nucleases) plasmids and sorting for CD47 negative cells.